China is the most rapidly growing and developing economy in the world today. Many companies have already entered the Chinese market, each of whom have different expectations and results. Other businesses, like Recip AB, are on their way to explore and expand world business to China. Combined with economic reform, China is going through a healthcare system reform, that is strongly related to the case company. An in depth intro of the healthcare system and the ongoing reform will provide the business with plenty of information for future action in the Chinese healthcare market. Pharmaceuticals are special products, which are typically highly controlled around the globe. The Chinese pharmaceutical market is performing a restructuring to split up the function of administration and enterprise, and is expecting a huge development in the near future. The co-operation between the USA, Europe and China will definitely assist the Chinese pharmaceutical market to develop on the right course. Fieldwork was conducted in China in May 1999, and was very fruitful…
Contents: The Chinese pharmaceutical market
1. INTRODUCTION
1.1 RESEARCH BACKGROUND
1.2 BRIEF INTRODUCTION OF RECIP AB AND ITS CORE PRODUCTS
1.3 THE OVERVIEW OF HEALTHCARE SYSTEM IN CHINA
1.4 THE POTENTIAL OF CHINESE PHARMACEUTICAL MARKET
1.4.1 OTC Pharmaceutical Market in China
1.4.2 The Future Trends of the Chinese Pharmaceutical Market
1.5 PURPOSE OF THESIS
1.6 THE MAIN PROBLEM OF THESIS
1.7 RESEARCH PROCEDURE
1.8 DISPOSITION OF THE THESIS
2. THE THEORETICAL FRAMEWORK
2.1 INSTITUTIONAL NETWORK THEORY
2.2 THE NETWORK-INSTITUTIONS MODEL
2.2.1 Economic Environment
2.2.2 Political Environment
2.2.3 Legal / Regulatory Environment
2.2.4 Social and Cultural Environment
2.2.5 Demographic Environment
2.2.6 Technology Environment
2.2.7 Internal Environment (Organisational Fields)
2.3 NETWORK STRATEGY
2.3.1 The Web Strategy
2.3.2 The Linkage Strategy
2.3.2.1 Types of Linkages (Relationships)
2.3.3 The Competitive Strategy
2.3.4 First-mover Advantages
2.4 THE MNC-GOVERNMENT NETWORK STRATEGY MODEL
2.5 SCIENTIFIC RESEARCH MODEL
3. METHODOLOGY
3.1 RESEARCH STRATEGY
3.2 RESEARCH METHOD SELECTION
3.2.1 Quantitative and Qualitative Approaches
3.3 CASE STUDY DESIGN
3.4 DATA COLLECTION
3.4.1 Data Sources
3.4.2 Collection Methods
3.4.3 Population and Sample
3.4.4 Questionnaires Design
3.5 EVALUATION
3.5.1 Error Sources
3.5.2 Validity
3.5.3 Reliability
4. ANALYSIS OF MACRO BUSINESS ENVIRONMENT
4.1 SOCIAL-CULTURAL BACKGROUND
4.1.1 Confucianism
4.1.2 The Maoism Influence and Cultural Revolution
4.2 BUSINESS NETWORK IN CHINA
4.2.1 Negotiation
4.3 THE POLITICAL SYSTEM
4.4 THE LEGAL SYSTEM
4.5 ECONOMIC ENVIRONMENT
4.6 TECHNOLOGICAL ENVIRONMENT
5. CHINESE HEALTHCARE SYSTEM
5.1 REVIEW OF CHINESE HEALTHCARE SYSTEM
5.2 THE DRIVING FORCES OF THE HEALTHCARE REFORM
5.3 CHINESE HEALTHCARE REFORM
5.3.1 Healthcare Financing System Reform
5.3.1.1 The History of Healthcare Financing System in China
5.3.1.2 Launch of State Essential Drug List for Reimbursement
5.3.1.3 New Scheme for Healthcare Insurance in 1999
5.3.2 China’s Commercial Medical Insurance Market
5.3.2.1 Review for Chinese Insurance Market
5.3.2.2 Commercial Medical Insurance in China
5.3.2.3 Medical Insurance in Rural Area
5.3.3 China’s Drug Pricing Reform and Drug Pricing Policy
5.3.3.1 The Problems in the Chinese Drug Pricing System
5.3.3.2 Basic Contents of China’s Drug Pricing Reform
5.3.3.3 Prospects of Price Reform in China’s Drug Market and Medical Service
5.3.4 Healthcare Infrastructure
6. ANALYSIS OF CHINESE PHARMACEUTICAL MARKET
6.1 THE OVERVIEW OF THE CHINESE PHARMACEUTICAL INDUSTRY
6.2 THE STRATEGY OF DEVELOPING THE CHINESE MEDICAL INDUSTRY
6.3 THE CO-OPERATION WITH THE FDA AND EUROPEAN PHARMACEUTICAL INDUSTRY
6.4 CHINESE PHARMACEUTICAL MARKET
6.4.1 Driving Forces for the Growth of Pharmaceutical Market
6.4.2 The OTC Drug Market in China
6.5 PHARMACEUTICAL DISTRIBUTION CHANNEL IN CHINA
6.6 INTELLECTUAL PROPERTY PROTECTION IN CHINA
6.7 THE OPPORTUNITIES AND THREATS OF THE CHINESE PHARMACEUTICAL MARKET
6.7.1 Problems and Challenges
6.7.2 The Future of Chinese Pharmaceutical Market
7. CASE STUDY: MARKET STRATEGY FOR AMINESS
7.1 INTRODUCTION OF RENAL INSUFFICIENCY
7.2 TREATMENT OF RENAL INSUFFICIENCY IN CHINA
7.3 OVERVIEW OF THE MARKET SURVEY
7.4 RESULTS AND ANALYSIS OF THE MARKET SURVEY
7.4.1 General Description of the Sample Hospitals
7.4.2 Healthcare Financing
7.4.3 The Treatment of Chronic Renal Insufficiency in China
7.4.4 Product survey
7.4.5 Product Promotion Survey
7.4.6 Product Distribution Channel and Purchase Decision Making
7.5 MARKETING STRATEGIES FOR AMINESS
7.5.1 Mapping of Government Network
7.5.2 Main Objectives
7.5.3 Strategic Capacity Profiles
7.5.3.1 Authority Specialist
7.5.3.2 Procedure Specialist
7.5.3.3 Intermediary Specialist
7.5.4 Linking Process
7.5.5 Network Strategy
7.5.5.1 Web Strategy
7.5.5.2 Linkage Strategies
7.5.5.3 Competitive Strategies
7.5.5.4 First, Second -mover Advantages
8. CONCLUSION AND RECOMMENDATIONS
8.1 CONCLUSION
8.1.1 Research Area 1: Institutional Analysis
8.1.1.1 Economic Factors
8.1.1.2 Political /Legal factors
8.1.1.3 Social /Cultural factors
8.1.1.4 Technological Factors….
Source: Goteborg University
Download URL 2: Visit Now